Britain first in the world to approve a vaccine against omicron strain

Moderna has received UK approval for a new bivalent vaccine that quadruples the number of virus-neutralizing omicron antibodies.Medical facilities will receive the drug by the end of August

In the UK, a booster dose of the vaccine from Moderna, adapted for two strains of CORONAVIRUS - the original Wuhan and Omicron, has been approved, it will begin to be used for vaccination of adults. The decision was taken by the Medicines and Healthcare Products Regulatory Agency (MHRA), the government of the kingdom said.

“The SARS-CoV-2 virus is constantly evolving to bypass the immunity supported by vaccines. The new bivalent vaccine represents the next step in the development of drugs to fight the virus, as it is able to induce a broader immune response than the original vaccine,” said Munir Pirmohamed, Chairman of the Commission for Human Medicines.

The bivalent vaccine also induces a good immune response against the omicron-strain subvariants BA.4 and BA.5, the results of the study said.

Popova predicted an increase in the incidence due to new omicron strains Society

One half of the new vaccine (25 micrograms) targets the original coronavirus strain, the other half (25 micrograms) targets Omicron. According to the results of the studies, side effects after the use of the bivalent vaccine were the same as with the original booster dose of Moderna. They were easy and passed without medical intervention, without causing serious HEALTH consequences, according to the website of the British government.

Clinical studies have shown that an adapted booster, when prevaccinated with three doses of the original covid-19 vaccine , causes an eight-fold increase in the number of antibodies against "omicron", writes the Financial Times. The bivalent booster made it possible to obtain 1.75 times more antibodies during the studies than in people who were vaccinated for the fourth time with an already existing vaccine.

The first deliveries of the bivalent dose of the vaccine will arrive in the UK by the end of August, Moderna plans. The company explained that production began several months before obtaining permission from the regulator. Moderna noted that the data needed to approve the drug was also provided to regulators in the European Union, CANADA and Australia, but the MHRA made the decision faster than others.

Read on RBC Pro Pro You will have to pay more:5 secrets of working with Chinese partners Articles Pro "Playground for adults":What it's like to work at GOOGLE - in 6 points Articles Pro Soviet wellness: are healing methods effective,friends from childhood Articles Pro "The Worst Corporation" in the world:what it's like to work at Walmart in 4 points Articles Pro How to relax,to have time to recuperate over the weekend Instructions Pro "You're just a cog":what it's like to work at MICROSOFT - in 5 points Articles Pro Left the company - so a traitor:What is it like to work in Chinese companies Articles Pro How to change brand design at different stages of development ArticlesPro How to change brand design at different stages of development ArticlesPro How to change brand design at different stages of development Articles

In RUSSIA, almost 28 thousand infected with coronavirus were detected per day Society

Another pharmaceutical company, Pfizer, plans to begin shipping the drug, adapted to the BA.4 and BA.5 variants of omicron, by October this year. The company began production of a vaccine against the BA.1 variant of the omicron strain back in the spring, but European and American regulators have still not issued a license for it.

The spread of new strains of "omicron" threatens to increase the incidence in Russia, warned the HEAD of Rospotrebnadzor Anna Popova. At the same time, she noted that they do not lead to an increase in seriously ill patients. At the Center. N.F. Gamalei created a platform against three new types of "omicron" (BA.1, BA.2, BA.5), DIRECTOR Alexander Gintsburg said, pointing out the difficulties with its implementation.

“Now the question of regulation is not clear how the tests will be carried out. According to the current rules, the tests will take five to six months. But during this time a new strain will appear, ”the academician warned.
 

See also Transformer substation on fire in Dzhankoy 00:06